Knight Therapeutics Inc banner

Wall St Price Targets

KHTRF Price Forecast
Based on 10 analysts

+11% Upside
from $8.41 today

Knight Therapeutics Inc (KHTRF)’s 12-month stock price forecast through November 2027 has a consensus target of $9.34, implying 11% upside. The forecast is based on price targets from 10 Wall Street analysts.

KHTRF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for KHTRF yet.

Knight Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is KHTRF's stock price target?
Price Target
9.34 USD

According to Wall Street analysts, the average 1-year price target for KHTRF is 9.34 USD with a low forecast of 7.83 USD and a high forecast of 10.56 USD.

What is the Revenue forecast for Knight Therapeutics Inc?
Projected CAGR
7%

Over the last 10 years, the compound annual growth rate for Revenue has been 84%. The projected CAGR for the next 5 years is 7%.

What is the Gross Profit forecast for Knight Therapeutics Inc?
Projected CAGR
9%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 79%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Knight Therapeutics Inc?
Projected CAGR
101%

The compound annual growth rate for Operating Income over the next 3 years is 101%.

Back to Top